Pages that link to "Q39095759"

The following pages link to Clinical response and plasma levels: effect of dose, dosage schedules, and drug interactions on plasma chlorpromazine levels (Q39095759):

Displaying 44 items.

• Ventricular fibrillation due to lithium withdrawal--an interaction with chlorpromazine? (Q28354379) (← links)
• The use of a side effect as a qualitative indicator of plasma chlorpromazine levels (Q28371844) (← links)
• Assessment of anti-psychotic drugs (Q34448621) (← links)
• A study of prophylactic value of antiparkinsonian drug (Q34449314) (← links)
• Predictive indices for chlorpromazine therapy in schizophrenics (Q34512216) (← links)
• Pharmacokinetics and interactions of headache medications, part I: introduction, pharmacokinetics, metabolism and acute treatments (Q36662888) (← links)
• Anti-schizophrenic drugs—Membrane receptor sites of action (Q37796814) (← links)
• Treatment of Chronic Schizophrenia (Q37808693) (← links)
• Plasma Level Monitoring of Antipsychotic Drugs (Q38242954) (← links)
• Development of HepG2-derived cells expressing cytochrome P450s for assessing metabolism-associated drug-induced liver toxicity (Q38827021) (← links)
• Drug response and psychiatric nosology (Q39224072) (← links)
• Antischizophrenic drugs: Differential plasma protein binding and therapeutic activity (Q39270687) (← links)
• Lithium-induced increase in the metabolism of benzo[a]pyrene and drugs in rat liver (Q39707504) (← links)
• Phenothiazines (Q40087570) (← links)
• The clinical use of antipsychotic medications. (Q40088289) (← links)
• Blood Levels of Flupenthixol in Patients with Acute and Chronic Schizophrenia (Q40458416) (← links)
• Emergency treatment of psychotic symptoms. Pharmacokinetic considerations for antipsychotic drugs. (Q40472062) (← links)
• Clinical pharmacokinetics of antipsychotics (Q40623519) (← links)
• Clinical effects and drug concentrations in plasma and cerebrospinal fluid in psychotic patients treated with fixed doses of chlorpromazine (Q40940702) (← links)
• Clinically significant interactions of psychotropic agents with antipsychotic drugs (Q41241532) (← links)
• Levels of chlorpromazine and its active metabolites in rat brain and the relationship to central monoamine metabolism and prolactin secretion (Q41286992) (← links)
• Dose-response relationships for the antipsychotic effects and Parkinsonian side-effects of typical neuroleptic drugs: Practical and theoretical implications (Q41676961) (← links)
• Plasma levels of neuroleptics vs clinical response (Q42147346) (← links)
• Neurochemical and psychoanalytical approaches to mania (Q42152479) (← links)
• Fluphenazine pharmacokinetics and therapeutic response (Q42257495) (← links)
• Smoking and body weight influence the clearance of chlorpromazine (Q47382298) (← links)
• Neuroleptic blood levels and clinical response (Q47598657) (← links)
• A simple and sensitive radioreceptor assay for antischizophrenic drugs in blood (Q48251559) (← links)
• Prediction of treatment response in schizophrenia: clinical use of neuroleptic blood levels (Q48486017) (← links)
• Serum levels and clinical response in long-term pharmacotherapy with zuclopenthixol decanoate (Q52081048) (← links)
• A comparative uptake study of serotonin, dopamine, and norepinephrine by platelets of acute schizophrenic patients (Q52103352) (← links)
• Differential reversal of various dopamine antagonists by anticholinergics in sidman avoidance: possible relationship to adrenergic blockade (Q52296152) (← links)
• Effect of a drug holiday on plasma chlorpromazine levels in chronic schizophrenic patients (Q64787854) (← links)
• Measurement of Plasma and Erythrocyte Chlorpromazine and N-Monodesmethylchlorpromazine Levels by Gas Chromatography with a Nitrogen Sensitive Detector (Q67026405) (← links)
• Serum concentrations of the isomers of clopenthixol and a metabolite in patients given cis(Z)-clopenthixol decanoate in viscoleo (Q70453171) (← links)
• Correlation between serotonin uptake and imipramine binding in schizophrenic patients (Q70680417) (← links)
• High dosage haloperidol therapy in chronic schizophrenic patients: a double-blind study of clinical response, side effects, serum haloperidol, and serum prolactin (Q71498525) (← links)
• Concentrations of chlorpromazine and two of its active metabolites in plasma and cerebrospinal fluid of psychotic patients treated with fixed drug doses (Q71548590) (← links)
• Serum concentrations of cis(Z)-flupentixol and prolactin in chronic schizophrenic patients treated with flupentixol and cis(Z)-flupentixol decanoate (Q71621628) (← links)
• SI units and sodium (Q72435379) (← links)
• Pharmacokinetic interaction between propranolol and chlorpromazine in schizophrenic patients (Q72435395) (← links)
• Does a plasma level of chlorpromazine help? (Q72518517) (← links)
• Serum neuroleptic concentrations and clinical response: a radioreceptor assay investigation of acutely psychotic patients (Q72578551) (← links)
• Interaction study between remoxipride and biperiden (Q72579636) (← links)